Literature DB >> 23647001

The role of tetrahydrobiopterin and catecholamines in the developmental regulation of tyrosine hydroxylase level in the brain.

Daigo Homma1, Setsuko Katoh, Hirofumi Tokuoka, Hiroshi Ichinose.   

Abstract

Tyrosine hydroxylase (TH) is a rate-limiting enzyme for dopamine synthesis and requires tetrahydrobiopterin (BH4) as an essential cofactor. BH4 deficiency leads to the loss of TH protein in the brain, although the underlying mechanism is poorly understood. To give insight into the role of BH4 in the developmental regulation of TH protein level, in this study, we investigated the effects of acute and subchronic administrations of BH4 or dopa on the TH protein content in BH4-deficient mice lacking sepiapterin reductase. We found that BH4 administration persistently elevated the BH4 and dopamine levels in the brain and fully restored the loss of TH protein caused by the BH4 deficiency in infants. On the other hand, dopa administration less persistently increased the dopamine content and only partially but significantly restored the TH protein level in infant BH4-deficient mice. We also found that the effects of BH4 or dopa administration on the TH protein content were attenuated in young adulthood. Our data demonstrate that BH4 and catecholamines are required for the post-natal augmentation of TH protein in the brain, and suggest that BH4 availability in early post-natal period is critical for the developmental regulation of TH protein level.
© 2013 International Society for Neurochemistry.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23647001     DOI: 10.1111/jnc.12287

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  7 in total

Review 1.  Tetrahydrobiopterin and Its Multiple Roles in Neuropsychological Disorders.

Authors:  S Swathi Krishna; Samson K Wilson
Journal:  Neurochem Res       Date:  2022-02-10       Impact factor: 3.996

Review 2.  Tetrahydrobiopterin in antenatal brain hypoxia-ischemia-induced motor impairments and cerebral palsy.

Authors:  Jeannette Vasquez-Vivar; Zhongjie Shi; Kehuan Luo; Karthikeyan Thirugnanam; Sidhartha Tan
Journal:  Redox Biol       Date:  2017-08-03       Impact factor: 11.799

3.  Sepiapterin reductase gene-disrupted mice suffer from hypertension with fluctuation and bradycardia.

Authors:  Chiho Sumi-Ichinose; Yui Suganuma; Taiki Kano; Noriko Ihira; Hiroko Nomura; Kazuhisa Ikemoto; Tadayoshi Hata; Setsuko Katoh; Hiroshi Ichinose; Kazunao Kondo
Journal:  Physiol Rep       Date:  2017-03

4.  Structural mechanism for tyrosine hydroxylase inhibition by dopamine and reactivation by Ser40 phosphorylation.

Authors:  María Teresa Bueno-Carrasco; Jorge Cuéllar; Marte I Flydal; César Santiago; Trond-André Kråkenes; Rune Kleppe; José R López-Blanco; Miguel Marcilla; Knut Teigen; Sara Alvira; Pablo Chacón; Aurora Martinez; José M Valpuesta
Journal:  Nat Commun       Date:  2022-01-10       Impact factor: 17.694

Review 5.  Brain Kynurenine and BH4 Pathways: Relevance to the Pathophysiology and Treatment of Inflammation-Driven Depressive Symptoms.

Authors:  Sylvie Vancassel; Lucile Capuron; Nathalie Castanon
Journal:  Front Neurosci       Date:  2018-07-24       Impact factor: 4.677

6.  Sapropterin Treatment Prevents Congenital Heart Defects Induced by Pregestational Diabetes Mellitus in Mice.

Authors:  Anish Engineer; Tana Saiyin; Xiangru Lu; Andrew S Kucey; Brad L Urquhart; Thomas A Drysdale; Kambiz Norozi; Qingping Feng
Journal:  J Am Heart Assoc       Date:  2018-11-06       Impact factor: 5.501

Review 7.  Sepiapterin reductase: Characteristics and role in diseases.

Authors:  Yao Wu; Peng Chen; Li Sun; Shengtao Yuan; Zujue Cheng; Ligong Lu; Hongzhi Du; Meixiao Zhan
Journal:  J Cell Mol Med       Date:  2020-07-30       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.